Year: 2025

37.8% of voting rights present or represented All resolutions were approvedMADRID and CAMBRIDGE, Mass., Dec. 15, 2025 (GLOBE NEWSWIRE) — Oryzon Genomics S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and global leader in epigenetics, today announced the results of voting at the Extraordinary General Shareholders’ Meeting held last Friday in Madrid. A total of 33,581,589 of the Company’s issued and outstanding voting rights (representing 37.7938% of the share capital) were at the Meeting, either in person or represented by proxy. The Company’s shareholders approved all of the resolutions listed below, proposed by the Board of Directors at the Company’s Extraordinary General Shareholders’ Meeting, with favorable votes ranging from 93% to 98%.Technical amendment of Article...

Cergy, France, 15 December 2025 – SPIE, the independent European leader in multi-technical services in the areas of energy and communications, announces the signing of a European framework agreement with Tesla relating to the implementation of battery energy storage system (BESS) projects. This agreement, with a renewable term of three years, applies to all European SPIE group subsidiaries with BESS installation expertise. It strengthens the collaboration between the two companies that is founded on several completed or ongoing projects in Belgium, the Netherlands and France. The agreement showcases the SPIE group’s ability to implement structured project organisation to manage strategic projects. A single framework to support the growth of energy storage in Europe Energy storage is a vital component of the energy transition, enabling...

SHENZHEN, CHINA, Dec. 15, 2025 (GLOBE NEWSWIRE) — China Medical System Holdings Limited (“CMS”, or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health which is applying for an independent listing on the Main Board of The Stock Exchange of Hong Kong Limited, please refer to the announcement of the Company dated 22 April 2025 for details), has obtained the relevant licensing rights to the innovative oral JAK1 inhibitor povorcitinib (proposed English generic name: Povorcitinib Phosphate Tablets) (“povorcitinib” or the “Product”), which has been included in the list of Breakthrough Therapeutic Drugs by the Center for Drug Evaluation of the National Medical Products Administration of the People’s Republic of China (“NMPA”), with...

Tel Aviv, Israel, Dec. 15, 2025 (GLOBE NEWSWIRE) — Jeffs’ Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace, which recently began expanding into the global homeland security sector through advanced AI-driven solutions, today announced that its wholly owned subsidiary, KeepZone AI Inc., (“KeepZone”), has signed an exclusive distribution agreement with Zorronet Ltd. (”Zorronet”), an innovative Israeli deep-tech company specializing in autonomous AI-driven security platform, which is a subsidiary of Water.io,and is majority-owned by Star 26 Capital Inc., which is subject to a pending acquisition by Nukkleus Inc. (Nasdaq: NUKK). The purpose of this strategic partnership is to enhance KeepZone’s security solutions portfolio by integrating...

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 15, 2025 (GLOBE NEWSWIRE) — Aftermath Silver Ltd. (TSXV: AAG) (OTCQX: AAGFF) (FSE: FLM1) (the “Company” or “Aftermath Silver“) is pleased to announce that it has entered into an agreement with Research Capital Corporation as the sole bookrunner and co-lead agent (and together with Red Cloud Securities Inc. as co-lead agent, the “Agents”), in connection with a brokered, best-efforts listed issuer financing exemption private placement offering (the “Offering”) of up to 16,666,667 common shares of the Company (the “Common Shares”) at a price of $0.90 per Common Share for aggregate gross proceeds to the Company of up to $15,000,000. Mr. Eric Sprott, through 2176423 Ontario...

Datavault AI’s International Name, Image and Likeness (“NIL”) Exchange will Solve for Regulatory Compliant with Quantum Encrypted Smart Contracts that will Present the Winning Solution PHILADELPHIA, Dec. 15, 2025 (GLOBE NEWSWIRE) — Datavault AI Inc. (NASDAQ: DVLT; the “Company” or “Datavault AI”), a leading provider of patented agentic AI platforms for data observation, valuation and monetization, today announced that former NHL player and Hockey Hall of Famer Jeremy Roenick is advising the Company to spearhead the development of its groundbreaking Sports and Entertainment initiative with the forthcoming International NIL Exchange. This strategic move builds on Datavault AI’s recent partnerships in sports and entertainment, including its World Boxing Council and Dream Bowl initiatives, unlocking unprecedented event-driven monetization...